Document quand l'auteur est "Chatenet, David"

Article

Billard, Étienne; Torbey, Alexandre; Inserra, Antonio; Grantham, Émily; Bertazzo, Antonella; De Gregorio, Danilo; Comai, Stephano; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Gobbi, Gabriella et Hébert, Terence E (2025). Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor Cellular Signalling , vol. 127 , nº 111588. pp. 1-13. DOI: 10.1016/j.cellsig.2025.

Trefier, Aurelie; Tousson-Abouelazm, Nihad; Yamani, Lama; Ibrahim, Salida; Joung, Kwang-Bo; Pietrobon, Adam; Yockell-Lelievre, Julien; Hébert, Terence E; Ladak, Reese J; Takano, Tomoko; Nellist, Mark; Namkung, Yoon; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Stanford, Willaim L; Laporte, Stephane A et Kristof, Arnold S (2024). Enhanced Gαq Signaling in TSC2-deficient Cells Is Required for Their Neoplastic Behavior American Journal of Respiratory Cell and Molecular Biology , vol. ahead . DOI: 10.1165/rcmb.2024-0111OC.

Nassour, Hassan; Pétrin, Darlaine; Devost, Dominic; Billard, Étienne; Sleno, Rory; Hébert, Terence E et Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 (2024). Evidence for heterodimerization and functional interaction of the urotensin II and the angiotensin II type 1 receptors Cell Signal , vol. ahead , nº 111056. DOI: 10.1016/j.cellsig.2024.111056. (Sous Presse)

Merlino, Francesco; Secondo, Agnese; Mitidieri, Emma; Sorrentino, Raffaella; Bellavita, Rosa; Grasso, Nicola; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Pannaccione, Anna; Grieco, Paolo; d’Emmanuele di Villa Bianca, Roberta et Carotenuto, Alfonso (2024). Expanding Structure-Activity Relationships of Human Urotensin II Peptide Analogues: A Proposed Key Role of the N-Terminal Region for Novel Urotensin II Receptor Modulators Journal of Medicinal Chemistry , vol. ahead . pp. 1-12. DOI: 10.1021/acs.jmedchem.4c0068. (Sous Presse)

Billard, Étienne; Hébert, Terence E et Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 (2023). Exploration of the Urocontrin a Scaffold Yields New Urotensinergic System Allosteric Modulator and Competitive Antagonists Biochemical Pharmacology , vol. 211 , nº 115485. pp. 1-10. DOI: 10.1016/j.bcp.2023.115485.

Dallagnol, Juliana C; Volkovich, Mikhail; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Allen, Bruce G. et Hébert, Terence E (2023). G Protein-Biased Agonists for Intracellular Angiotensin Receptors Promote Collagen Secretion in Myofibroblasts ACS chemical biology , vol. 18 , nº 9. pp. 2050-2062.

Fuselier, Camille; Dumoulin, Alyssa; Parent, Alex; Nehmé, Rita; Ajarrag, Samy; Granger Joly de Boissel, Philippine; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380 et St-Pierre, Yves ORCID: https://orcid.org/0000-0002-1948-2041 (2023). Placental Galectins in Cancer: Why We Should Pay More Attention Cells , vol. 12 , nº 3:437. pp. 1-15. DOI: 10.3390/cells12030437.

Wei, Xiaozheng; Diarra, Sitan; Douchez, Antoine; Dallagnol, Juliana C; Hébert, Terence E; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Lubell, William D (2023). Urotensin II Receptor Modulation with 1,3,4-Benzotriazepin-2-one Tetrapeptide Mimics Journal of Medicinal Chemistry , vol. 66 , nº 20. pp. 14241-14262. DOI: 10.1021/acs.jmedchem.3c01307.

Bui, Duong T; Li, Zhixiong; Kitov, Pavel I; Han, Ling; Kitova, Elena N; Fortier, Marlène; Fuselier, Camille; Granger Joly de Boissel, Philippine; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380; Tompkins, Stephen M; St-Pierre, Yves ORCID: https://orcid.org/0000-0002-1948-2041; Mahal, Lara K et Klassen, John S (2022). Quantifying Biomolecular Interactions Using Slow Mixing Mode (SLOMO) Nanoflow ESI-MS ACS Central Science , vol. 8 , nº 7. pp. 963-974. DOI: 10.1021/acscentsci.2c00215.

Mazarura, Grace R; Dallagnol, Juliana C; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Allen, Bruce G. et Hébert, Terence E (2022). The complicated lives of GPCRs in cardiac fibroblasts American journal of physiology. Cell physiology , vol. 323 , nº 3. C813-C822. DOI: 10.1152/ajpcell.00120.2022.

Ho, Eric; Deng, Yaoqi; Akbar, Dania; Da, Kevin; Létourneau, Myriam; Morshead, Cindi M; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Shoichet, Molly S (2022). Tunable Surface Charge Enables the Electrostatic Adsorption-Controlled Release of Neuroprotective Peptides from a Hydrogel-Nanoparticle Drug Delivery System ACS Applied Materials & Interfaces , vol. 15 , nº 1. pp. 91-105. DOI: 10.1021/acsami.2c17631.

Nassour, Hassan; Hoang, Tuan Anh; Martin, Ryan D; Dallagnol, Juliana C; Billard, Étienne; Létourneau, Myriam; Novellino, Ettore; Carotenuto, Alfonso; Allen, Bruce G.; Tanny, Jason C; Fournier, Alain; Hébert, Terence E et Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 (2021). Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands Journal of Biological Chemistry , vol. 297 , nº 3:101057. pp. 1-19. DOI: 10.1016/j.jbc.2021.101057.

Lopez de los Santos, Yossef; Bernard, David N.; Egesborg, Philippe; Létourneau, Myriam; Lafortune, Clara; Cuneo, Monica; Urvoas, Agathe; Chatenet, David; Mahy, Jean-Pierre; St-Pierre, Yves ORCID: https://orcid.org/0000-0002-1948-2041; Ricoux, Rémy et Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380 (2020). Binding of a Soluble meso-Tetraarylporphyrin to Human Galectin-7 Induces Oligomerization and Modulates Its Pro-Apoptotic Activity Biochemistry , vol. 59 , nº 48. pp. 4591-4600. DOI: 10.1021/acs.biochem.0c00736.

Chen, Jennifer J; Mbogning, Jean; Hancock, Mark A; Majdpour, Dorsa; Madhok, Manan; Nassour, Hassan; Dallagnol, Juliana C; Pagé, Viviane; Chatenet, David et Tanny, Jason C (2020). Spt5 phosphorylation and the Rtf1 Plus3 domain promote Rtf1 function through distinct mechanisms Molecular and Cellular Biology , vol. 40 , nº 15:e0015. pp. 1-23. DOI: 10.1128/MCB.00150-20.

Lamine, Asma; Poujol de Molliens, Mathilde; Létourneau, Myriam; Hébert, Terence E; Vaudry, David; Fournier, Alain et Chatenet, David (2019). The amidated PACAP1-23 fragment is a potent reduced-size neuroprotective agent Biochimica et Biophysica Acta , vol. 1863 , nº 11: 129410. pp. 1-10. DOI: 10.1016/j.bbagen.2019.08.003.

Poujol de Molliens, Mathilde; Jamadagni, Priyanka; Létourneau, Myriam; Devost, Dominic; Hébert, Terence E; Patten, Shunmoogum A.; Fournier, Alain et Chatenet, David (2019). Design and biological assessment of membrane-tethering neuroprotective peptides derived from the pituitary adenylate cyclase-activating polypeptide type 1 receptor Biochimica et Biophysica acta , vol. 1863 , nº 11: 129398. pp. 1-11. DOI: 10.1016/j.bbagen.2019.07.007.

Merlino, Francesco; Billard, Étienne; Yousif, Ali Munaim; Di Maro, Salvatore; Brancaccio, Diego; Abate, Luigi; Carotenuto, Alfonso; Bellavita, Rosa; d'Emmanuele di Villa Bianca, Roberta; Santicioli, Paola; Marinelli, Luciana; Novellino, Ettore; Hébert, Terence E; Lubell, William D; Chatenet, David et Grieco, Paolo (2019). Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides Journal of Medicinal Chemistry , vol. 62 , nº 3. pp. 1455-1467. DOI: 10.1021/acs.jmedchem.8b01601.

Billard, Étienne; Iddir, Mustapha; Nassour, Hassan; Lee-Gosselin, Laura; Poujol de Molliens, Mathilde et Chatenet, David (2019). New directions for urotensin II receptor ligands Peptide Science , vol. 111 , nº e24056. pp. 1-9. DOI: 10.1002/pep2.24056.

Liao, Chenyi; Poujol de Molliens, Mathilde; Schneebeli, Severin T.; Brewer, Matthias; Song, Gaojie; Chatenet, David; Braas, Karen M.; May, Victor et Li, Jianing (2019). Targeting the PAC1 Receptor for Neurological and Metabolic Disorders Current Topics in Medicinal Chemistry , vol. 19 , nº 16. pp. 1399-1417. DOI: 10.2174/1568026619666190709092647.

Nassour, Hassan; Iddir, Mustapha et Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 (2019). Towards Targeting the Urotensinergic System: Overview and Challenges Trends in Pharmacological Sciences , vol. 40 , nº 10. pp. 725-734. DOI: 10.1016/j.tips.2019.08.005.

Debbabi, Somia; Groleau, Marie-Christine; Létourneau, Myriam; Narayanan, Chitra; Lee-Gosselin, Laura; Iddir, Mustapha; Gagnon, Jacinthe; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380; Déziel, Éric ORCID: https://orcid.org/0000-0002-4609-0115 et Chatenet, David (2018). Antibacterial properties of the pituitary adenylate cyclase-activating polypeptide: A new human antimicrobial peptide. PLoS ONE , vol. 13 , nº 11:e0207366. pp. 1-15. DOI: 10.1371/journal.pone.0207366.

Billard, Étienne; Hébert, Terence E et Chatenet, David (2018). Discovery of New Allosteric Modulators of the Urotensinergic System through Substitution of the Urotensin II-Related Peptide (URP) Phenylalanine Residue Journal of Medicinal Chemistry , vol. 61 , nº 19. pp. 8707-8716. DOI: 10.1021/acs.jmedchem.8b00789.

Poujol de Molliens, Mathilde; Létourneau, Myriam; Devost, Dominic; Hébert, Terence E; Fournier, Alain et Chatenet, David (2018). New insights about the peculiar role of the 28-38 C-terminal segment and some selected residues in PACAP for signaling and neuroprotection Biochemical Pharmacology , vol. 154 . pp. 193-202. DOI: 10.1016/j.bcp.2018.04.024.

Billard, Étienne; Létourneau, Myriam; Hébert, Terence E et Chatenet, David (2017). Insight into the role of Urotensin II-Related Peptide Tyrosine residue in UT activation Biochemical Pharmacology , vol. 144 . pp. 100-107. DOI: 10.1016/j.bcp.2017.08.003.

Strack, Martin; Billard, Étienne; Chatenet, David et Lubell, William D (2017). Urotensin core mimics that modulate the biological activity of urotensin-II related peptide but not urotensin-II Bioorganic and Medicinal Chemistry Letters , vol. 27 , nº 15. pp. 3412-3416. DOI: 10.1016/j.bmcl.2017.05.088.

Tadevosyan, Artavazd; Xiao, Jiening; Surinkaew, Sirirat; Naud, Patrice; Merlen, Clémence; Harada, Masahide; Qi, Xiaoyan; Chatenet, David; Fournier, Alain; Allen, Bruce G. et Nattel, Stanley (2017). Intracellular Angiotensin-II Interacts With Nuclear Angiotensin Receptors in Cardiac Fibroblasts and Regulates RNA Synthesis, Cell Proliferation, and Collagen Secretion Journal of the American Heart Association , vol. 6 , nº 4. e004965-1. DOI: 10.1161/jaha.116.004965.

Thamri, Amal; Létourneau, Myriam; Djboulian, Alex; Chatenet, David; Déziel, Éric ORCID: https://orcid.org/0000-0002-4609-0115; Castonguay, Annie ORCID: https://orcid.org/0000-0001-5705-6353 et Perreault, Jonathan (2017). Peptide modification results in the formation of a dimer with a 60-fold enhanced antimicrobial activity PLoS One , vol. 12 , nº 3. : e0173783: 1-12. DOI: 10.1371/journal.pone.0173783.

Chatenet, David et Hébert, Terence E (2017). Understanding GPCR signaling in the brain- the path to CNS drug discovery Current Opinion in Pharmacology , vol. 32 . v-vii. DOI: 10.1016/j.coph.2017.03.001.

Douchez, Antoine; Billard, Étienne; Hébert, Terence E; Chatenet, David et Lubell, William D (2017). Design, Synthesis, and Biological Assessment of Biased Allosteric Modulation of the Urotensin II Receptor Using Achiral 1,3,4-Benzotriazepin-2-one Turn Mimics Journal of Medicinal Chemistry , vol. 60 , nº 23. pp. 9838-9859. DOI: 10.1021/acs.jmedchem.7b01525.

Lamine, Asma; Létourneau, Myriam; Doan, Ngoc Duc; Maucotel, Julie; Couvineau, Alain; Vaudry, Hubert; Chatenet, David; Vaudry, David et Fournier, Alain (2016). Characterizations of a synthetic pituitary adenylate cyclase-activating polypeptide analog displaying potent neuroprotective activity and reduced in vivo cardiovascular side effects in a Parkinson's disease model Neuropharmacology , vol. 108 . pp. 440-450. DOI: 10.1016/j.neuropharm.2015.05.014.

Tadevosyan, Artavazd; Villeneuve, Louis R.; Fournier, Alain; Chatenet, David; Nattel, Stanley et Allen, Bruce G. (2016). Caged ligands to study the role of intracellular GPCRs Methods , vol. 92 . pp. 72-77. DOI: 10.1016/j.ymeth.2015.07.005.

Lamine-Ajili, Asma; Fahmy, Ahmed Mohamed; Létourneau, Myriam; Chatenet, David; Labonté, Patrick; Vaudry, David et Fournier, Alain (2016). Effect of the pituitary adenylate cyclase-activating polypeptide on the autophagic activation observed in in vitro and in vivo models of Parkinson's disease Biochimica et Biophysica Acta - Molecular Basis of Disease , vol. 1862 , nº 4. pp. 688-695. DOI: 10.1016/j.bbadis.2016.01.005.

Merlino, Francesco; Yousif, Ali Munaim; Billard, Étienne; Dufour-Gallant, Julien; Turcotte, Stéphane; Grieco, Paolo; Chatenet, David et Lubell, William D (2016). Urotensin II(4-11) Azasulfuryl Peptides: Synthesis and Biological Activity Journal of Medicinal Chemistry , vol. 59 , nº 10. pp. 4740-4752. DOI: 10.1021/acs.jmedchem.6b00108.

Dufour-Gallant, Julien; Chatenet, David et Lubell, William D (2015). De Novo Conception of Small Molecule Modulators Based on Endogenous Peptide Ligands: Pyrrolodiazepin-2-one gamma-Turn Mimics That Differentially Modulate Urotensin II Receptor-Mediated Vasoconstriction ex Vivo Journal of Medicinal Chemistry , vol. 58 , nº 11. pp. 4624-37. DOI: 10.1021/acs.jmedchem.5b00162.

Vladoiu, Maria Claudia; Labrie, Marilyne; Létourneau, Myriam; Egesborg, Philippe; Gagné, Donald; Billard, Étienne; Grosset, Andrée-Anne; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380; Chatenet, David et St-Pierre, Yves (2015). Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin Oncotarget , vol. 6 , nº 38. pp. 40970-80. DOI: 10.18632/oncotarget.5403.

Vaudry, Hubert; Leprince, Jérôme; Chatenet, David; Fournier, Alain; Lambert, David G; Le Mével, Jean-Claude; Ohlstein, Eliot H; Schwertani, Adel; Tostivint, Hervé et Vaudry, David (2015). International Union of Basic and Clinical Pharmacology. XCII. Urotensin II, Urotensin II-Related Peptide, and Their Receptor: From Structure to Function Pharmacological Reviews , vol. 67 , nº 1. pp. 214-58. DOI: 10.1124/pr.114.009480.

Doan, Ngoc Duc; Poujol de Molliens, Mathilde; Létourneau, Myriam; Fournier, Alain et Chatenet, David (2015). Optimization of on-resin palladium-catalyzed Sonogashira cross-coupling reaction for peptides and its use in a structure-activity relationship study of a class B GPCR ligand European Journal of Medicinal Chemistry , vol. 104 . pp. 106-114. DOI: 10.1016/j.ejmech.2015.09.017.

Tadevosyan, Artavazd; Létourneau, Myriam; Folch, Benjamin; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380; Villeneuve, Louis R.; Mamarbachi, Aida M; Pétrin, Darlaine; Hébert, Terence E; Fournier, Alain; Chatenet, David; Allen, Bruce G. et Nattel, Stanley (2015). Photoreleasable ligands to study intracrine angiotensin II signalling Journal of Physiology , vol. 593 , nº 3. pp. 521-539. DOI: 10.1113/jphysiol.2014.279109.

Nguyen, Thi Tuyet Nhung; Folch, Benjamin; Létourneau, Myriam; Truong, Nam Hai; Doucet, Nicolas; Fournier, Alain et Chatenet, David (2014). Design of a truncated cardiotoxin-I analogue with potent insulinotropic activity Journal of Medicinal Chemistry , vol. 57 , nº 6. pp. 2623-33. DOI: 10.1021/jm401904q.

Tchoumi Neree, Armelle; Nguyen, Phuong Trang; Chatenet, David; Fournier, Alain et Bourgault, Steve (2014). Secondary conformational conversion is involved in glycosaminoglycans-mediated cellular uptake of the cationic cell-penetrating peptide PACAP FEBS Letters , vol. 588 , nº 24. pp. 4590-4596. DOI: 10.1016/j.febslet.2014.10.029.

Chatenet, David; Folch, Benjamin; Feytens, Debby; Létourneau, Myriam; Tourwé, Dirk; Doucet, Nicolas et Fournier, Alain (2013). Development and pharmacological characterization of conformationally constrained urotensin II-related peptide agonists Journal of Medicinal Chemistry , vol. 56 , nº 23. pp. 9612-9622. DOI: 10.1021/jm401153j.

Chatenet, David; Létourneau, Myriam; Nguyen, Quang Trinh; Doan, Ngoc Duc; Dupuis, Jocelyn et Fournier, Alain (2013). Discovery of new antagonists aimed at discriminating UII and URP-mediated biological activities: Insight into UII and URP receptor activation British Journal of Pharmacology , vol. 168 , nº 4. pp. 807-821. DOI: 10.1111/j.1476-5381.2012.02217.x.

Merlen, Clémence; Farhat, Nada; Luo, Xiaoyan; Chatenet, David; Tadevosyan, Artavazd; Villeneuve, Louis R.; Gillis, Marc-Antoine; Nattel, Stanley; Thorin, Eric; Fournier, Alain et Allen, Bruce G. (2013). Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca2+ in adult cardiac myocytes Journal of Molecular and Cellular Cardiology , vol. 62 . pp. 189-202. DOI: 10.1016/j.yjmcc.2013.05.021.

Vaniotis, George; Glazkova, Irina; Merlen, Clémence; Smith, Carter; Villeneuve, Louis R.; Chatenet, David; Therien, Michel; Fournier, Alain; Tadevosyan, Artavazd; Trieu, Phan; Nattel, Stanley; Hébert, Terence E et Allen, Bruce G. (2013). Regulation of cardiac nitric oxide signaling by nuclear β-adrenergic and endothelin receptors Journal of Molecular and Cellular Cardiology , vol. 62 . pp. 58-68. DOI: 10.1016/j.yjmcc.2013.05.003.

Doan, Ngoc-Duc; Nguyen, Thi Tuyet Mai; Letourneau, Myriam; Turcotte, Kathy; Fournier, Alain et Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 (2012). Biochemical and pharmacological characterization of nuclear urotensin-II binding sites in rat heart British Journal of Pharmacology , vol. 166 , nº 1. pp. 243-257. DOI: 10.1111/j.1476-5381.2011.01710.x.

Nguyen, Thi Tuyet Nhung; Folch, Benjamin; Létourneau, Myriam; Vaudry, David; Truong, Nam Hai; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Fournier, Alain (2012). Cardiotoxin-I: An Unexpectedly Potent Insulinotropic Agent Chembiochem , vol. 13 , nº 12. pp. 1805-1812. DOI: 10.1002/cbic.201200081.

Doan, Ngoc-Duc; Létourneau, Myriam; Vaudry, David; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380; Folch, Benjamin; Vaudry, Hubert; Fournier, Alain et Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 (2012). Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide Journal of Controlled Release , vol. 163 , nº 2. pp. 256-265. DOI: 10.1016/j.jconrel.2012.08.021.

Nguyen, Thi-Tuyet Mai; Létourneau, Myriam; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Fournier, Alain (2012). Presence of urotensin-II receptors at the cell nucleus: Specific tissue distribution and hypoxia-induced modulation International Journal of Biochemistry and Cell Biology , vol. 44 , nº 4. pp. 639-47. DOI: 10.1016/j.biocel.2011.12.022.

Doan, Ngoc-Duc; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Létourneau, Myriam; Vaudry, Hubert; Vaudry, David et Fournier, Alain (2012). Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide Biochimica et Biophysica Acta - Molecular Cell Research , vol. 1823 , nº 4. pp. 940-949. DOI: 10.1016/j.bbamcr.2012.02.001.

Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Nguyen, Thi-Tuyet M; Letourneau, Myriam et Fournier, Alain (2012). Update on the urotensinergic system: new trends in receptor localization, activation, and drug design Frontiers in endocrinology , vol. 3 . p. 174. DOI: 10.3389/fendo.2012.00174.

Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Nguyen, Quang-Trinh; Letourneau, Myriam; Dupuis, Jocelyn et Fournier, Alain (2012). Urocontrin, a novel UT receptor ligand with a unique pharmacological profile Biochemical Pharmacology , vol. 83 , nº 5. pp. 608-615. DOI: 10.1016/j.bcp.2011.12.009.

Fu, Yan; Létourneau, Myriam; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Dupuis, Jocelyn et Fournier, Alain (2011). Characterization of iodinated adrenomedullin derivatives suitable for lung nuclear medicine Nuclear Medicine and Biology , vol. 38 , nº 6. pp. 867-74. DOI: 10.1016/j.nucmedbio.2011.01.011.

Doan, Ngoc-Duc; Bourgault, Steve; Dejda, Agnieszka; Létourneau, Myriam; Detheux, Michel; Vaudry, David; Vaudry, Hubert; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Fournier, Alain (2011). Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects Biochemical Pharmacology , vol. 81 , nº 4. pp. 552-561. DOI: 10.1016/j.bcp.2010.11.015.

Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Cescato, Renzo; Waser, Beatrice; Erchegyi, Judit; Rivier, Jean E. et Reubi, Jean Claude (2011). Novel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers EJNMMI research , vol. 1 , nº 1. p. 21. DOI: 10.1186/2191-219X-1-21.

Bourgault, Steve; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Wurtz, Olivier; Doan, Ngoc Duc; Leprince, Jérôme; Vaudry, Hubert; Fournier, Alain et Vaudry, David (2011). Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug Current Pharmaceutical Design , vol. 17 , nº 10. pp. 1002-1024. DOI: 10.2174/138161211795589337.

Jarry, Marie; Diallo, Mickaël; Lecointre, Céline; Desrues, Laurence; Tokay, Tursonjan; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Leprince, Jérôme; Rossi, Oriana; Vaudry, Hubert; Tonon, Marie-Christine; Prezeau, Laurent; Castel, Hélène et Gandolfo, Pierrick (2010). The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation Biochemical Journal , vol. 428 , nº 1. pp. 113-124. DOI: 10.1042/BJ20090867.

Vaudry, Hubert; Do Rego, Jean-Claude; Le Mevel, Jean-Claude; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Tostivint, Hervé; Fournier, Alain; Tonon, Marie-Christine; Pelletier, Georges; Conlon, John Michael et Leprince, Jérôme (2010). Urotensin II, from fish to human Annals of the New York Academy of Sciences , vol. 1200 . pp. 53-66. DOI: 10.1111/j.1749-6632.2010.05514.x.

Fu, Yan; Létourneau, Myriam; Nguyen, Quang T.; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Dupuis, Jocelyn et Fournier, Alain (2009). Characterization of the adrenomedullin receptor acting as the target of a new radiopharmaceutical biomolecule for lung imaging European Journal of Pharmacology , vol. 617 , nº 1-3. pp. 118-123. DOI: 10.1016/j.ejphar.2009.06.031.

Dubessy, Christophe; Cartier, Dorthe; Lectez, Benoît; Bucharles, Christine; Chartrel, Nicolas; Montero-Hadjadje, Maïté; Bizet, Patrice; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Tostivint, Hervé; Scalbert, Elizabeth; Leprince, Jérôme; Vaudry, Hubert; Jegou, Sylvie et Lihrmann, Isabelle (2008). Characterization of urotensin II, distribution of urotensin II, urotensin II-related peptide and UT receptor mRNAs in mouse: evidence of urotensin II at the neuromuscular junction Journal of Neurochemistry , vol. 107 , nº 2. pp. 361-374. DOI: 10.1111/j.1471-4159.2008.05624.x.

Desrues, Laurence; Lefebvre, Thomas; Diallo, Mickaël; Gandolfo, Pierrick; Leprince, Jérôme; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Vaudry, Hubert; Tonon, Marie-Christine et Castel, Hélène (2008). Effect of GABA A receptor activation on UT-coupled signaling pathways in rat cortical astrocytes Peptides , vol. 29 , nº 5. pp. 727-734. DOI: 10.1016/j.peptides.2008.01.024.

Chuquet, Julien; Lecrux, Clotilde; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Leprince, Jérôme; Chazalviel, Laurent; Roussel, Simon; MacKenzie, Eric T; Vaudry, Hubert et Touzani, Omar (2008). Effects of urotensin-II on cerebral blood flow and ischemia in anesthetized rats Experimental Neurology , vol. 210 , nº 2. pp. 577-584. DOI: 10.1016/j.expneurol.2007.12.004.

Leprince, Jérôme; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Dubessy, Christophe; Fournier, Alain; Pfeiffer, Bruno; Scalbert, Elizabeth; Renard, Pierre; Pacaud, Pierre; Oulyadi, Hassan; Ségalas-Milazzo, Isabelle; Guilhaudis, Laure; Davoust, Daniel; Tonon, Marie-Christine et Vaudry, Hubert (2008). Structure-activity relationships of urotensin II and URP Peptides , vol. 29 , nº 5. pp. 658-673. DOI: 10.1016/j.peptides.2007.08.014.

Diallo, Mickaël; Jarry, Marie; Desrues, Laurence; Castel, Hélène; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Leprince, Jérôme; Vaudry, Hubert; Tonon, Marie-Christine et Gandolfo, Pierrick (2008). [Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes Peptides , vol. 29 , nº 5. pp. 813-819. DOI: 10.1016/j.peptides.2007.10.023.

Bruzzone, Federica; Lectez, Benoît; Alexandre, David; Jegou, Sylvie; Mounien, Lourdes; Tollemer, Hélène; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Leprince, Jérôme; Vallarino, Mauro; Vaudry, Hubert et Chartrel, Nicolas (2007). Distribution of 26RFa binding sites and GPR103 mRNA in the central nervous system of the rat Journal of Comparative Neurology , vol. 503 , nº 4. pp. 573-591. DOI: 10.1002/cne.21400.

Bruzzone, Federica; Lectez, Benoît; Tollemer, Hélène; Leprince, Jérôme; Dujardin, Cynthia; Rachidi, Walid; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Baroncini, Marc; Beauvillain, Jean-Claude; Vallarino, Mauro; Vaudry, Hubert et Chartrel, Nicolas (2006). Anatomical distribution and biochemical characterization of the novel RFamide peptide 26RFa in the human hypothalamus and spinal cord Journal of Neurochemistry , vol. 99 , nº 2. pp. 616-627. DOI: 10.1111/j.1471-4159.2006.04090.x.

Castel, Hélène; Diallo, Mickaël; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Leprince, Jérôme; Desrues, Laurence; Schouft, Marie-Thérèse; Fontaine, Marc; Dubessy, Christophe; Lihrmann, Isabelle; Scalbert, Elizabeth; Malagon, Maria; Vaudry, Hubert; Tonon, Marie-Christine et Gandolfo, Pierrick (2006). Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes Journal of Neurochemistry , vol. 99 , nº 2. pp. 582-595. DOI: 10.1111/j.1471-4159.2006.04130.x.

Leprince, Jérôme; Cosquer, David; Bellemere, Gaëlle; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Tollemer, Hélène; Jegou, Sylvie; Tonon, Marie-Christine et Vaudry, Hubert (2006). Catabolism of the octadecaneuropeptide ODN by prolyl endopeptidase: identification of an unusual cleavage site Peptides , vol. 27 , nº 6. pp. 1561-1569. DOI: 10.1016/j.peptides.2005.11.024.

Jegou, Sylvie; Cartier, Dorthe; Dubessy, Christophe; Gonzalez, Bruno J; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Tostivint, Hervé; Scalbert, Elizabeth; Leprince, Jérôme; Vaudry, Hubert et Lihrmann, Isabelle (2006). Localization of the urotensin II receptor in the rat central nervous system Journal of Comparative Neurology , vol. 495 , nº 1. pp. 21-36. DOI: 10.1002/cne.20845.

Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Dubessy, Christophe; Boularan, Cédric; Scalbert, Elizabeth; Pfeiffer, Bruno; Renard, Pierre; Lihrmann, Isabelle; Pacaud, Pierre; Tonon, Marie-Christine; Vaudry, Hubert et Leprince, Jérôme (2006). Structure-activity relationships of a novel series of urotensin II analogues: identification of a urotensin II antagonist Journal of Medicinal Chemistry , vol. 49 , nº 24. pp. 7234-7238. DOI: 10.1021/jm0602110.

Do-Rego, Jean-Claude; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Orta, Marie-Hélène; Naudin, Bertrand; Le Cudennec, Camille; Leprince, Jérôme; Scalbert, Elizabeth; Vaudry, Hubert et Costentin, Jean (2005). Behavioral effects of urotensin-II centrally administered in mice Psychopharmacology , vol. 183 , nº 1. pp. 103-117. DOI: 10.1007/s00213-005-0140-2.

Chartrel, Nicolas; Leprince, Jérôme; Dujardin, Cynthia; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Tollemer, Hélène; Baroncini, Marc; Balment, Richard J.; Beauvillain, Jean-Claude et Vaudry, Hubert (2004). Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord Journal of Neurochemistry , vol. 91 , nº 1. pp. 110-118. DOI: 10.1111/j.1471-4159.2004.02698.x.

Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Dubessy, Christophe; Leprince, Jérôme; Boularan, Cédric; Carlier, Ludovic; Ségalas-Milazzo, Isabelle; Guilhaudis, Laure; Oulyadi, Hassan; Davoust, Daniel; Scalbert, Elizabeth; Pfeiffer, Bruno; Renard, Pierre; Tonon, Marie-Christine; Lihrmann, Isabelle; Pacaud, Pierre et Vaudry, Hubert (2004). Structure-activity relationships and structural conformation of a novel urotensin II-related peptide Peptides , vol. 25 , nº 10. pp. 1819-1830. DOI: 10.1016/j.peptides.2004.04.019.

Silvestre, Ramona A.; Egido, Eva M.; Hernandez, Raquel; Leprince, Jérôme; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Tollemer, Hélène; Chartrel, Nicolas; Vaudry, Hubert et Marcoux, José (2004). Urotensin-II is present in pancreatic extracts and inhibits insulin release in the perfused rat pancreas European Journal of Endocrinology , vol. 151 , nº 6. pp. 803-809. DOI: 10.1530/eje.0.1510803.

Labarrere, Patricia; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Leprince, Jérôme; Marionneau, Céline; Loirand, Gervaise; Tonon, Marie-Christine; Dubessy, Christophe; Scalbert, Elizabeth; Pfeiffer, Bruno; Renard, Pierre; Calas, Bernard; Pacaud, Pierre et Vaudry, Hubert (2003). Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction Journal of Enzyme Inhibition and Medicinal Chemistry , vol. 18 , nº 2. pp. 77-88. DOI: 10.1080/1475636031000093507.

Grison, Claude; Comoy, Corinne; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Coutrot, Philippe (2002). Synthesis of P-chiral enephosphonic acid derivatives Journal of Organometallic Chemistry , vol. 662 , nº 1–2. pp. 83-97. DOI: 10.1016/S0022-328X(02)01889-2.

Chapitre de livre

Bourque, Kyla; Dallagnol, Juliana C; Nassour, Hassan; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Allen, Bruce G. et Hébert, Terence E (2022). Exploring the use of intracellular and extracellular allosteric modulators to understand GPCR signaling In: Allosteric Modulation of G Protein-Coupled Receptors. Academic Press, San Diego, pp. 135-160.

Bourque, Kyla; Dallagnol, Juliana C. C.; Nassour, Hassan; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Allen, Bruce G. et Hébert, Terence E. (2022). Exploring the use of intracellular and extracellular allosteric modulators to understand GPCR signaling In: Allosteric Modulation of G Protein-Coupled Receptors. Academic Press, San Diego, pp. 135-160.

Chatenet, David; Bourgault, Steve et Fournier, Alain (2015). Design and application of light-activated probes for cellular signaling In: Nuclear G-Protein Coupled Receptors. Methods in Molecular Biology, 1234 (1234). Springer, New York, pp. 17-30.

Vaudry, David; Burel, Delphine; Galas, Ludovic; Lacaille, Hélène; Duterte-Boucher, Dominique; Chatenet, David; Fournier, Alain et Vaudry, Hubert (2013). PACAP In: Handbook of Biologically Active Peptides. Elsevier B.V., -, pp. 1038-1043.

Document issu d'une conférence ou d'un atelier

Cauwenbergh, Thibault; Dallagnol, Juliana C; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Martin, Charlotte et Ballet, Steven (2024). Optimization of antivasoconstricting UT-II-derived biogels In: 37th European Peptide Symposium 14th International Peptide Symposium, August 25-29, 2024, Florence, Italy.

Lubell, William D; Wei, Xiaozheng; Diarra, Sitan; Douchez, Antoine; Dallagnol, Juliana C; Harvey-Lavoie, Simonne; Hébert, Terence E et Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 (2024). Tetrasubstituted benzotriazepinones act as β-turn mimics without stereogenic carbons exhibiting allosteric modulation of the urotensin II receptor In: 37th European Peptide Symposium 14th International Peptide Symposium, August 25-29, 2024, Florence, Italy.

Fuselier, Camille; Dumoulin, Alyssa; Parent, Alex; Nehmé, Rita; Ajarrag, Samy; Granger Joly de Boissel, Philippine; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380 et St-Pierre, Yves ORCID: https://orcid.org/0000-0002-1948-2041 (2023). Development and characterization of galectin-13-specific nanobodies In: Annual Meeting of the Society for Glycobiology (SFG), November 05-08, 2023, Hawaii.

Nehmé, Rita; Fortier, Marlène; Létourneau, Myriam; Granger Joly de Boissel, Philippine; Dumoulin, Alyssa; Fuselier, Camille; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380 et St-Pierre, Yves ORCID: https://orcid.org/0000-0002-1948-2041 (2023). Galectin inhibitors: A new generation of single-domain antibodies to target both intracellular and extracellular galectins for cancer treatment In: Annual Meeting of the Society for Glycobiology (SFG), November 05-08, 2023, Hawaii.

Pham, Ngoc Thu Hang; Paré, Alex; Létourneau, Myriam; Fortier, Marlène; Begin, Gabriel; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; St-Pierre, Yves ORCID: https://orcid.org/0000-0002-1948-2041; Lague, Patrick; Calmettes, Charles ORCID: https://orcid.org/0000-0002-2542-4382 et Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380 (2022). Allosteric network analysis in galectin-7 uncovers key residues controlling positive cooperativity between two opposite glycan binding sites In: 36th Annual Symposium of the Protein-Society, July 07-10, 2022, San Francisco, CA.

Pham, Ngoc Thu Hang; Létourneau, Myriam; Fortier, Marlène; Hernandez, Carolina Perusquía; Pinoteau, Marie-Aude; Gagnon, Jacinthe; Egesborg, Philippe; Chatenet, David; St-Pierre, Yves ORCID: https://orcid.org/0000-0002-1948-2041; Calmettes, Charles et Doucet, Nicolas ORCID: https://orcid.org/0000-0002-1952-9380 (2019). Homodimer Interface Mutations of Human Galectin-7 alter Its Biological Activity In: 33rd Annual Symposium of the Protein-Society, 30-03 June-July 2019, Seattle, Washington.

Poujol de Molliens, Mathilde; Létourneau, Myriam; Hébert, Terry; Fournier, Alain et Chatenet, David (2016). Développement de modulateurs allo stériques intracellulaires du récepteur pac1 In: Journée Phare 2016 (8e édition), 1-2 décembre 2016, Bromont (Québec).

Vaudry, David; Doan, Ngoc Duc; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Bourgault, Steve; Dejda, Agnieszka; Basille, Magali; Botia, Béatrice; Vaudry, Hubert et Fournier, Alain (2012). Characterization of the neurotrophic effects of PACAP and development of new analogs for therapeutic applications In: Summer Neuropeptide Conference / Meeting of the European-Neuropeptide-Club (ENC), May 22-25, 2011, Boston, MA.

Doan, Ngoc Duc; Bourgault, Steve; Létourneau, Myriam; Vaudry, David; Detheux, Michel; Vaudry, Hubert; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Fournier, Alain (2012). How specific are the antagonists of PACAP receptors In: 10th International Symposium on VIP-PACAP and Related Peptides, December 13-16, 2011, Eilat, ISRAEL.

Doan, Ngoc Duc; Nguyen, Thi Tuyet Mai; Létourneau, Myriam; Vaudry, David; Vaudry, Hubert; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328 et Fournier, Alain (2012). Intracrine pharmacology of pituitary adenylate cyclase-activating polypeptide In: 10th International Symposium on VIP-PACAP and Related Peptides, December 13-16, 2011, Eilat, ISRAEL.

Vaniotis, George; Merlen, Clémence; Tadevosyan, Artavazd; Villeneuve, Louis R.; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; Zamboni, Robert; Fournier, Alain; Hébert, Terence E et Allen, Bruce G. (2012). Regulation of nitric oxide synthesis by beta-adrenergic receptors in the nuclear envelope In: Experimental Biology Meeting, April 21-25, 2012, San Diego, California,.

Pham, Ngoc Thu Hang; Parent, Alex; Létourneau, Myriam; Fortier, Marlène; Bégin, Gabriel; Chatenet, David ORCID: https://orcid.org/0000-0002-7270-4328; St-Pierre, Yves ORCID: https://orcid.org/0000-0002-1948-2041; Lagüe, Patrick et Calmettes, Charles ORCID: https://orcid.org/0000-0002-2542-4382 . Allosteric network analysis in galectin-7 uncovers key residues controlling positive cooperativity between two opposite glycan binding sites In: 4th Protein Engineering Canada (PEC) Conference, June 21-23, 2022, Montréal (Québec).

Poujol de Molliens, Mathilde; Létourneau, Myriam; Hébert, Terry; Fournier, Alain et Chatenet, David . Conception de ligands biaisés neuroprotecteurs dérivés du PACAP pour le traitement de la maladie de Parkinson In: Congrès Armand-Frappier 2017 (10e édition), 9-11 novembre 2017, Orford (Québec).

Chatenet, David; Létourneau, Myriam et Fournier, Alain . Conception et caractérisation de modulateurs du système urotensinergique. In: Congrès Armand-Frappier 2009, 6e édition, 5-7 novembre 2009, Bromont.

Thamri, Amal; Létourneau, Myriam; Chatenet, David; Castonguay, Annie ORCID: https://orcid.org/0000-0001-5705-6353 et Perreault, Jonathan . Cystein-functionalization of an Antimicrobial Peptide Allows the Spontaneous Formation of a Dimer with a 30-fold Enhanced Antimicrobial Activity In: 99th Canadian Chemistry Conference and Exhibition, June 5-9, 2016, Halifax, Nouvelle-Écosse, Canada.

Poujol de Molliens, Mathilde; Létourneau, Myriam; Hébert, Terence E; Fournier, Alain et Chatenet, David . Développement de modulateur allostériques intracellulaire de récepteur PAC1 In: 1ère journée scientifique de l'axe pharmacologie et toxicologie, 28 octobre 2016, INRS - Institut Armad-Frapper, Laval, Qc, Canada.

Lamine, Asma; Létourneau, Myriam; Chatenet, David; Vaudry, David et Fournier, Alain . Étude de l'effet neuroprotecteur du PACAP sur l'excitotoxicité et l'inflammation, deux phénomènes observés au cours de la maladie de Parkinson In: 8e édition, Congrès Armand-Frappier 2013, 14-16 novembre 2013, Orford (Québec).

Billard, Étienne; Létourneau, Myriam et Chatenet, David . Étude des relations structure-activité sur la position 6 de l’urotensine related peptide. In: 9e édition, Congrès Armand-Frappier 2015, 12-14 novembre 2015, Orford (Québec).

Iddir, Mustapha; Hébert, Terence E et Chatenet, David . Implication de l'oligomérisation du récepteur ut dans la sélectivité foctionelle de l'urotensine II et de l'urotensine II-related peptide In: 1ère journée scientifique de l'axe pharmacologie et toxicologie, 28 octobre 2016, INRS- Institut Armand-Frapper, Laval, Qc, Canada.

Iddir, Mustapha; Létourneau, Myriam; Hébert, Terry et Chatenet, David . Implication de l'oligomérisation du récepteur ut dans la sélectivité fonctionnelle de l'urotensine ii et de l'urotensin ii-related peptide In: Congrès Armand-Frappier 2017 (10e édition), 9-11 novembre 2017, Orford (Québec).

Pham, Ngoc Thu Hang; Létourneau, Myriam; Pinoteau, Marie-Aude; Fortier, Marlène; Gagnon, Jacinthe; Egesborg, Philippe; Chatenet, David; St-Pierre, Yves; Calmettes, Charles et Doucet, Nicolas . Insights into the Homodimeric Interface of Human Galectin-7: From Structural and BiophysicalCharacterization to Immunosuppressive Activity Assays In: 32nd Annual Symposium of The Protein Society, July 9-12 2018, Boston, Masachusetts.

Lee-Gosselin, Laura; Létourneau, Myriam et Chatenet, David . L'acide aminée PHE-6 joue un rôle significatif dans l'activité biologique du pacap, un peptide neuroprotecteur In: 1ère journée scientifique de l'axe pharmacologie et toxicologie, 28 octobre 2016, INRS - Institut Armad-Frapper, Laval, Qc, Canada.

Ngoc Duc, Doan; Chatenet, David; Létourneau, Myriam et Fournier, Alain . Le pituitary adenylate-cyclase activating polypetide: thérapie potentielle pour les maladies neurodégénératives. In: Congrès Armand-Frappier 2009, 6e édition, 5-7 novembre 2009, Bromont.

Nguyen, Thi Tuyet Mai; Létourneau, Myriam; Turcotte, Kathy; Chatenet, David et Fournier, Alain . Localisation nucléaire du récepteur de l'urotensine II chez le rat. In: Congrès Armand-Frappier 2009, 6e édition, 5-7 novembre 2009, Bromont.

Gosselin, Laura-Lee; Létourneau, Myriam; Chatenet, David et Fournier, Alain . L’acide aminé phe-6 joue un rôle significatif dans l’activité biologique du PACAP, un peptide neuroprotecteur In: Journée Phare 2016 (8e édition), 1-2 décembre 2016, Bromont (Québec).

Billard, Étienne; Létourneau, Myriam; Hébert, Terry et Chatenet, David . Mise en lumière du méchanisme d'activation du récepteur UT In: 1ère journée scientifique de l'axe pharmacologie et toxicologie, 28 octobre 2016, INRS- Institut Armand-Frapper, Laval, Qc, Canada.

Billard, Étienne; Létourneau, Myriam; Hébert, Terry et Chatenet, David . Mise en lumière du rôle du résidu Tyr6 de l’Urotensin II-related peptide dans l’activation d’UT In: Congrès Armand-Frappier 2017 (10e édition), 9-11 novembre 2017, Orford (Québec).

Nguyen, Thi Tuyet Nhung; Létourneau, Myriam; Chatenet, David et Fournier, Michel . Poisons naturels ou médecine de demain: identification de deux toxines à fort potentiel thérapeutique dans le venin du serpent Naja Kaouthia. In: Congrès Armand-Frappier 2009, 6e édition, 5-7 novembre 2009, Bromont.